This biotech close-end fund sports a venture capital sleeve. Read More
Analyst Articles
Drugmakers are increasingly outsourcing their clinical trials. Read More
This small-cap growth fund pursues a risk-averse strategy. Read More
A stealth stock that offers a steady dividend. Read More
Fund investors often get burned chasing returns, particularly in volatile markets. But chastened investors who seek refuge in balanced funds don’t have to settle for a boring investment strategy. Read More
Small-cap stocks outperform the market over the long term, but their returns often come with fearful volatility. Anxious investors can turn to this risk-averse fund when seeking small- and mid-cap exposure. Read More